Skip to content
Review

A cross-sectional evaluation of racial and ethnic differences in apparent treatment resistant hypertension among US adults.

Aug 2026 · Journal of the American Pharmacists Association · pp. 103497 · 0 citations
Medicine

TL;DR

Non-Hispanic Blacks bear disproportionate burden in aTRH while Hispanics are likely undertreated, although small sample size in the former group limits conclusive findings.

Abstract

Background

Treatment resistant hypertension (TRH) represents a major public health challenge in the United States, substantially increasing risks of major cardiovascular events. The racial and ethnic differences in prescribing patterns and outcomes of treatment resistant hypertension are not well characterized.

Objectives

This study exams racial differences in TRH epidemiology, treatment and outcomes in a national sample of hypertensive adults.

Methods

We analyzed US adults (≥18 years) with hypertension from the National Health and Nutrition Examination Survey (NHANES) 2017-2020 (N=4,174). Apparent treatment resistant hypertension (aTRH) was defined as uncontrolled blood pressure (systolic blood pressure, SBP≥130 mmHg or diastolic blood pressure, DBP≥80 mmHg) despite concurrent use of ≥3 antihypertensive classes including a diuretic or use of ≥4 medications regardless of blood pressure. Estimates were weighted to represent the US population.

Results

Among adults with hypertension, the overall prevalence of aTRH was 6.61 [CI: 5.58, 7.65]. Prevalence was the highest among non-Hispanic Blacks (9.57%), followed by non- Hispanic Whites (6.81%) and Hispanics (3.49%). Despite more antihypertensive medications (average number of antihypertensive medications: 3.87, 3.66 and 3.58 among Black, Whites and Hispanic participants, respectively; p <0.001), blood pressure levels were the highest among Black participants. Black participants had the lowest rate of BP control (10.5%) compared to Whites (23.8%) and Hispanics (14.4%) (Pdiff<0.01).

Conclusions

Non-Hispanic Blacks bear disproportionate burden in aTRH while Hispanics are likely undertreated, although small sample size in the former group limits conclusive findings. Further research is needed to disentangle the interrelationship between TRH, race and ethnicity and mediating factors.

View source

Similar papers

Clinical trial Open access Aug 2026

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Findings highlight the need for improved screening and optimized treatment of hypertension in people with HIV and explore the relationship between hypertension and MACE using cause-specific Cox proportional hazards models.

Risa M. Hoffman, Maya Watanabe, E. Martínez et al. · 0 citations
Open access Sep 2026

Hypertension prevalence, detection, treatment and control among 1.4 million adults in England: a cross-sectional analysis from the Our Future Health study in 2022–2025

Over one-third of adults in England had hypertension, yet only half of affected individuals were detected and half of those treated achieved blood pressure control, highlighting the need for population-wide prevention strategies alongside targeted treatment of individuals at high cardiovascular risk.

Wen-Yu Liu, J. Collister, T. Littlejohns et al. · 0 citations
Review Open access Sep 2026

Correlates of antihypertensive medication non-adherence among patients with hypertension

The findings argue compellingly for a multi-pronged intervention strategy to improve blood pressure control, reducing complications, and enhancing patient quality of life in Livingstone, Zambia.

J. P. Povia, B. Hamooya, P. Hangoma · 0 citations
Open access Oct 2026

Association of hypertension specialist treatment with blood pressure control in Japanese primary care: The J-DOME study.

Although hypertension is a major contributor to cardiovascular complications, real-world blood pressure (BP) control in primary care and the role of hypertension specialists remain incompletely characterized. We evaluated BP control and associated factors using the Japan Medical Association Database of Clinical Medicin...

D. Hirohama, Shigeru Shibata, Narumi Eguchi et al. · 0 citations
Open access Sep 2026

Population burden of diabetes, hypertension, and cardiovascular disease attributable to obesity: a community-based study in Türkiye

Obesity has emerged as a global public health pandemic, with rapidly increasing prevalence and a growing burden of obesity-related chronic diseases worldwide. Despite its high prevalence, obesity remains underdiagnosed, limiting effective prevention and management. Reliable, region-specific epidemiological data are...

Banu Ersoy Şen, Meltem Yılmaz, Merve Taştan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.